AstraZeneca News
Here are all todays headlines related to AstraZeneca News. If you wish to drill deeper to view past AstraZeneca News items, follow the next 20 headlines link at the foot of the page.
06-03-2020
The FTSE 100 is down 195 points at 6,510 but even on a day of widescale carnage, there are some bright spots. Pharma stocks are also regarded as defensive investments, which may account for why ...
27-02-2020
The long-term prospects of FTSE 100 shares AstraZeneca plc (LON:AZN) (AZN.L), National Grid plc (LON:NG) (NG.L) and Fresnillo Plc (LON:FRES) (FRES.L) are relatively positive in my opinion. Fresnillo ...
17-02-2020
Barclays set a GBX 8,500 ($111.81) target price on AstraZeneca (LON:AZN) in a research note published on Friday, Borsen Zeitung reports. The brokerage currently has a buy rating on the ...
27-01-2020
AstraZeneca PLC (LON:AZN) is take back the rights to brazikumab, an antibody currently being tested to treat inflammatory bowel diseases such as Crohn’s disease. The drug was licensed to Allergan plc ...
06-01-2020
JP Morgan’s top pick in the big caps was AstraZeneca PLC (LON:AZN), as it is set to launch its Farxiga for heart failure while news on the progress of adjuvant lung cancer candidate Tagrisso and ...
02-01-2020
To keep the lesson grounded in practicality, we'll use ROE to better understand AstraZeneca PLC (LON:AZN). AstraZeneca has a ROE of 14%, based on the last twelve months. That means that for every £1 ...
31-12-2019
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
30-12-2019
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
20-12-2019
The FTSE 100-listed firm already sold commercial rights in the US in 2017, while now the drugs have lost exclusive rights in most countries in Europe and Africa AstraZeneca PLC (LON:AZN) has agreed to ...
05-12-2019
Analysts said the prevalence of the BRCA-mutated ovarian cancer is higher in China and the approval will boost AstraZeneca’s already strong performance in the region AstraZeneca PLC’s (LON:AZN) ...
03-12-2019
This is part of the Anglo-Swedish giant's focus on its core R&D portfolio and bunch blockbusters it owns As part of its focus on its core drugs portfolio, AstraZeneca PLC (LON:AZN) is divesting the US ...
29-11-2019
Anglo-Swedish drugs giant AstraZeneca PLC (LON:AZN) has been granted a priority review for a new drug’s use in a particularly aggressive and untreated form of lung cancer. Imfinzi, which is already ...
14-11-2019
The application is for the use of selumetinib in children aged three years and older. NF1 is a rare and incurable genetic condition that causes skin abnormalities and non-cancerous tumours AstraZeneca ...
29-10-2019
StockMarketWire.com - Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 8000p (from 7700p).
15-10-2019
StockMarketWire.com - Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 6700p (from 6550p).
04-10-2019
AstraZeneca PLC (LON:AZN) has been given US clearance for its self-administered pen version of severe asthma treatment Fasenra, one of its fastest-growing drugs. Self-administrated and pen variations ...
AZN Headlines - Does AstraZeneca's (LON:AZN) Share Price Gain of 66% Match Its Business Performance?
02-10-2019
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses is one path to excess returns. To wit, the AstraZeneca share price has climbed ...
30-09-2019
Sector peer AstraZeneca PLC (LON:AZN), down 1.9% at 7,242p, was faring less well after it also made a couple of announcements, including one about Lynparza, the ovarian cancer treatment it is ...
18-09-2019
AstraZeneca (LON:AZN) has moved to amend a deal with Ironwood to take control of Linzess in China, the Anglo-Swedish drugmaker has said. The move comes after the two companies first entered into a ...
02-09-2019
StockMarketWire.com - Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 7600p (from 7200p).
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price